Arbutus Biopharma Corp (ABUS) has 12 open-market insider trades by 4 insiders since 2015. The most active filer is Michael J. Sofia, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael J. Sofia | CSO | — | 7 | $1.7M | 2024-02-02 |
| Michael J. McElhaugh | CEOPres | — | 3 | $400K | 2025-02-14 |
| Keith S. Manchester | Dir | — | 1 | $33K | 2024-08-14 |
| Richard C. Henriques Jr. | Dir | — | 1 | $7K | 2015-08-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael J. McElhaugh | CEO & President | Sell | $156K | 2025-02-04 |
| J. Christopher Naftzger | General Counsel and CCO | Sell | $37K | 2025-02-04 |
| Karen Sims | — | Sell | $127K | 2025-02-04 |
| David C. Hastings | CFO | Sell | $146K | 2025-02-04 |
| Keith S. Manchester | Director | Sell | $33K | 2024-08-14 |
| Karen Sims | Chief Medical Officer | Sell | $10K |
Companies that share insiders with ABUS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-02-02 |
| Michael J. McElhaugh | President | Sell | $23K | 2024-02-02 |
| David C. Hastings | CFO | Sell | $22K | 2024-02-02 |
| Michael J. Sofia | Chief Scientific Officer | Sell | $23K | 2024-02-02 |
| Michael J. Sofia | CSO | Sell | $1.0M | 2021-12-01 |
| Michael J. McElhaugh | — | Sell | $100K | 2021-02-09 |
| Michael J. McElhaugh | — | Sell | $200K | 2020-12-14 |
| Michael J. McElhaugh | — | Sell | $100K | 2020-07-23 |
| Michael J. Sofia | Chief Scientific Officer | Sell | $40K | 2018-08-13 |
| Michael J. Sofia | CSO | Sell | $100K | 2018-07-11 |